Terms: = Endocrine gland cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
21 results:
1. The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment.
Iesato A; Li S; Sadow PM; Abbasian M; Nazarian A; Lawler J; Nucera C
Thyroid; 2023 Jul; 33(7):835-848. PubMed ID: 37171127
[No Abstract] [Full Text] [Related]
2. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
[TBL] [Abstract] [Full Text] [Related]
4. Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.
Shi YH; Xu QC; Zhu YQ; Liu ZD; Zhao GY; Liu Q; Wang XY; Wang JQ; Xu X; Su Q; Lai JM; Huang CS; Yin XY
Mol Ther; 2023 Feb; 31(2):503-516. PubMed ID: 36384875
[TBL] [Abstract] [Full Text] [Related]
5. Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460.
Zhu XX; Li JH; Ni X; Wu X; Hou X; Li YX; Li SJ; Zhao W; Yin XY
Cancer Sci; 2022 Nov; 113(11):3735-3750. PubMed ID: 36047966
[TBL] [Abstract] [Full Text] [Related]
6. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
[TBL] [Abstract] [Full Text] [Related]
7. The expression of Platelet-derived Growth factor receptors (pdgfrs) and their correlation with overall survival of patients with ovarian cancer.
Szubert S; Moszynski R; Szpurek D; Romaniuk B; Sajdak S; Nowicki M; Michalak S
Ginekol Pol; 2019; 90(5):242-249. PubMed ID: 30977516
[TBL] [Abstract] [Full Text] [Related]
8. Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting cancer Cell Glycolysis.
Hu LP; Zhang XX; Jiang SH; Tao LY; Li Q; Zhu LL; Yang MW; Huo YM; Jiang YS; Tian GA; Cao XY; Zhang YL; Yang Q; Yang XM; Wang YH; Li J; Xiao GG; Sun YW; Zhang ZG
Clin Cancer Res; 2019 Feb; 25(4):1318-1330. PubMed ID: 30420446
[TBL] [Abstract] [Full Text] [Related]
9. Melatonin Synergizes with Sorafenib to Suppress Pancreatic cancer via Melatonin Receptor and pdgfr-β/STAT3 Pathway.
Fang Z; Jung KH; Yan HH; Kim SJ; Rumman M; Park JH; Han B; Lee JE; Kang YW; Lim JH; Hong SS
Cell Physiol Biochem; 2018; 47(5):1751-1768. PubMed ID: 29953970
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI.
Kieler M; Müllauer L; Koperek O; Bianconi D; Unseld M; Raderer M; Prager GW
Oncology; 2018; 94(5):306-310. PubMed ID: 29444511
[TBL] [Abstract] [Full Text] [Related]
11. Cotargeting of MEK and pdgfr/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
[TBL] [Abstract] [Full Text] [Related]
12. Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivation.
Lee J; Lee WK; Seol MY; Lee SG; Kim D; Kim H; Park J; Jung SG; Chung WY; Lee EJ; Jo YS
Oncotarget; 2016 Oct; 7(41):66728-66739. PubMed ID: 27556512
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of lenvatinib in treating thyroid cancer.
Krajewska J; Kukulska A; Jarzab B
Expert Opin Pharmacother; 2016 Aug; 17(12):1683-91. PubMed ID: 27398740
[TBL] [Abstract] [Full Text] [Related]
14. Impact of p53 and pdgfr-β Expression on Metastasis and prognosis of Patients with Pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Sakoda M; Shinchi H; Natsugoe S
World J Surg; 2016 Aug; 40(8):1977-84. PubMed ID: 26940582
[TBL] [Abstract] [Full Text] [Related]
15. The Relationship between Intraoperative Rupture and Recurrence of Pediatric Ovarian Neoplasms: Preliminary Observations.
Yousef Y; Pucci V; Emil S
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):111-6. PubMed ID: 26300232
[TBL] [Abstract] [Full Text] [Related]
16. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract] [Full Text] [Related]
17. KRAS, EGFR, pdgfr-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE).
Veits L; Schupfner R; Hufnagel P; Penzel R; Freitag J; Ströbel P; Kern MA; Schröder S; Neuhold N; Schmid KW; Schirmacher P; Hartmann A; Rieker RJ
Diagn Pathol; 2014 Jun; 9():116. PubMed ID: 24934485
[TBL] [Abstract] [Full Text] [Related]
18. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.
Mathey S; Graeser MK; Zu Eulenburg C; Woelber L; Trillsch F; Jaenicke F; Müller V; Milde-Langosch K; Mahner S
Oncology; 2013; 85(2):69-77. PubMed ID: 23860180
[TBL] [Abstract] [Full Text] [Related]
19. The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
Eichbaum M; Mayer C; Eickhoff R; Bischofs E; Gebauer G; Fehm T; Lenz F; Fricke HC; Solomayer E; Fersis N; Schmidt M; Wallwiener M; Schneeweiss A; Sohn C
BMC Cancer; 2011 Oct; 11():453. PubMed ID: 22014006
[TBL] [Abstract] [Full Text] [Related]
20. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas.
Fazio N; Cinieri S; Lorizzo K; Squadroni M; Orlando L; Spada F; Maiello E; Bodei L; Paganelli G; Delle Fave G; de Braud F
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S87-94. PubMed ID: 21129617
[TBL] [Abstract] [Full Text] [Related]
[Next]
